BWA vs DMAAR · P/E 41, rev $7.18B vs $1.8M cap
BorgWarner Inc (BWA) versus Drugs Made In America Acquisition Corp. Rights (DMAAR) — a side-by-side from cached financials, not a winner call.
BorgWarner Inc (BWA) is a auto parts company listed on NYSE.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Latest reported BWA revenue for 2026-06-30 was $7.18B. Net income was $519.0M. BWA currently screens at market cap $14.47B and trailing P/E 41.0.
DMAAR does not have a complete income-statement cache yet.
BWA currently screens at market cap $14.47B and trailing P/E 41.0. DMAAR currently screens at market cap $1.8M.
Not investment advice. Open the BWA and DMAAR stock pages for the full models.
Not investment advice.